Search Results

Stanford Medicine research on Timothy syndrome — which predisposes newborns to autism and epilepsy — may extend well beyond the rare genetic disorder to schizophrenia and other conditions.

Combining two cutting-edge technologies, researchers revealed the impact of a multitude of genes that are associated with neurodevelopmental disorders, including autism, but whose effects on human brain development were previously unknown.

Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.

Credited with sparking the field of genetic engineering, Stanford Medicine biochemist Paul Berg shared the 1980 Nobel Prize in chemistry for creating the first recombinant DNA molecule.

Old muscle stem cells express high levels of the cancer-associated molecule CD47. Blocking a pathway mediated by CD47 restored strength to old mice in a Stanford Medicine study.

A technique developed at Stanford Medicine allows mice with diabetes to accept unmatched islet cells and durably restores blood sugar control without immunosuppression or graft-versus-host disease.

Lab-grown clusters of human brain cells integrate so well into young rats’ brains they enable researchers to study neurodevelopmental disorders’ molecular and circuit underpinnings.

Stanford Medicine researchers have created a molecule that blocks an enzyme thought to be instrumental in causing colon cancer relapse or chemotherapy resistance.

Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.

Researchers found that damage to the brain’s white matter after COVID-19 resembles that seen after cancer chemotherapy, raising hope for treatments to help both conditions.